|
|
Article: Merck's Cozaar(R) cleared for marketing by FDA first in new class of blood pressure medications.
- Article from:
- Business Wire
- Article date:
- April 18, 1995
CopyrightCOPYRIGHT 1995 Business Wire. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
WEST POINT, Pa.--(BUSINESS WIRE)--April 18, 1995--Cozaar (losartan potassium tablets), a once-daily prescription medication that represents the first new class of medicines for the treatment of high blood pressure in more than a decade, has been cleared for marketing by the U.S. Food and Drug Administration, Merck & Co. Inc., announced Tuesday.
Cozaar is the first in a new class of effective antihypertensive drugs called Angiotensin-II (A-II) receptor blockers. Cozaar lowers high blood pressure by blocking A-II. A hormone, A-II causes narrowing of the blood vessels and salt and water retention by the kidneys. Cozaar blocks A-II, which resulted in gradual, smooth, ...